Danaher Co. (NYSE:DHR) SVP Angela S. Lalor sold 42,988 shares of the stock in a transaction that occurred on Friday, February 2nd. The stock was sold at an average price of $102.29, for a total transaction of $4,397,242.52. Following the sale, the senior vice president now owns 82,008 shares in the company, valued at $8,388,598.32. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
Shares of Danaher Co. (DHR) opened at $95.25 on Thursday. Danaher Co. has a fifty-two week low of $78.97 and a fifty-two week high of $104.82. The firm has a market cap of $67,361.22, a price-to-earnings ratio of 26.98, a PEG ratio of 2.03 and a beta of 1.04. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.43 and a quick ratio of 1.05.
Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.16 by $0.03. Danaher had a net margin of 13.60% and a return on equity of 11.36%. The business had revenue of $5.09 billion for the quarter, compared to analyst estimates of $4.97 billion. During the same period last year, the business earned $1.05 EPS. The company’s revenue was up 10.9% on a year-over-year basis. sell-side analysts anticipate that Danaher Co. will post 4.37 earnings per share for the current fiscal year.
Institutional investors and hedge funds have recently made changes to their positions in the company. Calton & Associates Inc. acquired a new stake in shares of Danaher in the 4th quarter valued at $114,000. GQG Partners LLC acquired a new stake in Danaher during the 2nd quarter worth $101,000. First Personal Financial Services raised its stake in Danaher by 128.9% during the 4th quarter. First Personal Financial Services now owns 1,227 shares of the conglomerate’s stock worth $114,000 after acquiring an additional 691 shares in the last quarter. Zions Bancorporation raised its stake in Danaher by 118.3% during the 3rd quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock worth $106,000 after acquiring an additional 667 shares in the last quarter. Finally, Resources Investment Advisors Inc. raised its stake in Danaher by 661.2% during the 4th quarter. Resources Investment Advisors Inc. now owns 1,530 shares of the conglomerate’s stock worth $142,000 after acquiring an additional 1,329 shares in the last quarter. Institutional investors and hedge funds own 76.19% of the company’s stock.
A number of equities research analysts have issued reports on the stock. Argus increased their target price on shares of Danaher from $100.00 to $115.00 and gave the stock a “buy” rating in a report on Thursday, February 1st. Royal Bank of Canada reiterated a “hold” rating and set a $98.00 target price on shares of Danaher in a report on Wednesday, January 31st. Stifel Nicolaus increased their target price on shares of Danaher from $110.00 to $115.00 and gave the stock a “buy” rating in a report on Wednesday, January 31st. Morgan Stanley increased their target price on shares of Danaher from $103.00 to $110.00 and gave the stock an “overweight” rating in a report on Wednesday, January 31st. Finally, Credit Suisse Group increased their target price on shares of Danaher from $99.00 to $105.00 and gave the stock an “outperform” rating in a report on Wednesday, January 31st. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company’s stock. Danaher presently has an average rating of “Buy” and an average price target of $100.13.
COPYRIGHT VIOLATION WARNING: This story was first published by Community Financial News and is the property of of Community Financial News. If you are accessing this story on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this story can be accessed at https://www.com-unik.info/2018/02/08/danaher-co-dhr-svp-angela-s-lalor-sells-42988-shares.html.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.